Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$12.80 – $18.28
15% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.61B | $12.57B | $13.45B | $15.78B | $18.69B | $18.12B | $17.98B | $16.84B |
| Cost of revenue | $4.63B | $4.99B | $6.15B | $7.09B | $9.55B | $9.08B | $8.42B | $8.72B |
| Gross profit | $5.97B | $7.58B | $7.30B | $8.68B | $9.13B | $9.04B | $9.56B | $8.12B |
| Gross margin | 56.3% | 60.3% | 54.3% | 55.0% | 48.9% | 49.9% | 53.2% | 48.2% |
| R&D | $506.0M | $981.0M | $1.15B | $1.39B | $1.41B | $1.55B | $1.49B | $837.1M |
| Operating income | $1.81B | $2.00B | $1.63B | $2.40B | $1.11B | $869.0M | $1.86B | $1.81B |
| EBITDA | $2.35B | $2.99B | $2.71B | $3.48B | $2.40B | $2.40B | $3.12B | $2.80B |
| Net income | $1.24B | $1.45B | $1.25B | $1.76B | $511.0M | $228.0M | $988.0M | $651.5M |
| Net margin | 11.7% | 11.6% | 9.3% | 11.1% | 2.7% | 1.3% | 5.5% | 3.9% |
| EPS (diluted) | 9.13 | 10.98 | 9.63 | 13.49 | 3.99 | 1.64 | 6.78 | 4.47 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $10.4B | $7.37 | $7.26–$7.43 | 4 |
| 2027 | $17.9B | $9.59 | $9.45–$9.67 | 4 |
| 2028 | $18.8B | $11.54 | $11.37–$11.63 | 5 |
| 2029 | $19.8B | $15.22 | $15.00–$15.35 | 4 |
Forward consensus · source: Financial Modeling Prep
GN GREAT NORDIC LTD
No one on the platform currently holds GGNDF.
No tracked institution reports a position in GGNDF as of their last filing.
No one on the platform has traded GGNDF yet.
| $1.8B |
| — |
| OSSUYEmbla Medical hf. | $3.81 | +0.00% | $1.6B | — |
| STSEYStratec SE | $5.51 | +0.00% | $1.7B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 2.5× earnings vs its 6.2× historical median P/E.
Fair value ≈ $34.11 · price $13.63 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.